Floyd 2022 Lancet

From Bioblast
Publications in the MiPMap
Floyd L, Stauss M, Woywodt A (2022) Is open access a misnomer? Lancet 399:P1226. https://doi.org/10.1016/S0140-6736(22)00107-6

Β» Open Access

Floyd L, Stauss M, Woywodt A (2022) Lancet

Abstract: As a group of clinicians, we voice our concerns about recent changes to publication fees. Having coauthored an original article together, we were faced with the dilemma of having to pay Β£2000 in publication fees. This contrasts with a situation only 2 years ago when publication in most journals was free of charge or only incurred a small administration fee. The situation was further compounded by the fact that these costs are similar across the major journals in our specialty (appendix). Our institution has no dedicated funds to cover publication fees, and we were faced with either having to pay ourselves or retracting the manuscript. It was later agreed that our department would cover the costs on a compassionate basis.

β€’ Bioblast editor: Gnaiger E




Cookies help us deliver our services. By using our services, you agree to our use of cookies.